Trials / Recruiting
RecruitingNCT06143631
Prescription of Letrozole for Uterine Myoma
Letrozole for Treatment of Uterine Fibroids: A Randomized, Placebo-Controlled Trial
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- Female
- Age
- 21 Years – 53 Years
- Healthy volunteers
- Accepted
Summary
The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Letrozole 2.5mg | Oral letrozole 2.5mg/day |
| OTHER | Placebo | Placebo capsule |
Timeline
- Start date
- 2024-07-24
- Primary completion
- 2027-01-30
- Completion
- 2027-04-30
- First posted
- 2023-11-22
- Last updated
- 2026-02-03
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06143631. Inclusion in this directory is not an endorsement.